Clinical Trial Update: Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating autologous bone marrow–derived cells for safety and efficacy in spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• bone marrow derived autologous cells

Snippet

Sponsor: Chaitanya Hospital, Pune | Conditions: Spinal Cord Injury. | Phase 1, Phase 2 | Status: UNKNOWN